Kazuhiro Murakami
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kazuhiro Murakami has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Masanobu Oshima
Division of Genetics, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
18 shared publications - Hiroko Oshima
Division of Genetics, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
14 shared publications - Mizuho Nakayama
Division of Genetics, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
13 shared publications - Hiroshi Saito
Department of Surgery Koseiren Takaoka Hospital Takaoka Japan
12 shared publications - Haruna Takeda
Laboratory of Molecular Genetics, National Cancer Center Research Institute, Tokyo, Japan
3 shared publications Kenji Kita
Kanazawa University Central Research Resource Branch, Cancer Research Institute Kakuma-machi, Kanazawa 920-1192, Japan
2 shared publications
Latest Publications
- Open Access
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Missense Mutant p53 Transactivates Wnt/β-Catenin Signaling in Neighboring p53-Destabilized Cells through the COX-2/PGE2 Pathway
TOPFLash analysis in COX-2 or EP2/EP4 inhibitor-treated AKTP R270H cells
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Missense Mutant p53 Transactivates Wnt/β-Catenin Signaling in Neighboring p53-Destabilized Cells through the COX-2/PGE2 Pathway
TOPFLash analysis in COX-2 or EP2/EP4 inhibitor-treated AKTP R270H cells
- Open Access
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Missense Mutant p53 Transactivates Wnt/β-Catenin Signaling in Neighboring p53-Destabilized Cells through the COX-2/PGE2 Pathway
IPA results for AKTP R270 vs AKTP Null cells
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Missense Mutant p53 Transactivates Wnt/β-Catenin Signaling in Neighboring p53-Destabilized Cells through the COX-2/PGE2 Pathway
IPA results for AKTP R270 vs AKTP Null cells
- Open Access
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Missense Mutant p53 Transactivates Wnt/β-Catenin Signaling in Neighboring p53-Destabilized Cells through the COX-2/PGE2 Pathway
Trp53 LOH analysis for AKTP R270H cells
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Missense Mutant p53 Transactivates Wnt/β-Catenin Signaling in Neighboring p53-Destabilized Cells through the COX-2/PGE2 Pathway
Trp53 LOH analysis for AKTP R270H cells
- Open Access
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Figure 3 from Missense Mutant p53 Transactivates Wnt/β-Catenin Signaling in Neighboring p53-Destabilized Cells through the COX-2/PGE2 Pathway
Activation of Wnt/β-catenin signaling in p53-negative cells through the COX-2/PGE2 pathway. A, Schematic drawing of Wnt/β-catenin reporter assays (TOPFlash) of co-cultured AKTPNull-bottom cells with AKTPR270H-top cells or AKTPNull-top cells. B, Luciferase activities of Wnt reporter assays (TOPFlash) of AKTPNull-bottom cells co-cultured with AKTPNull-top cells or AKTPR270H-top cells are shown as a bar graph (mean ± SD). Each dot represents an independent experiment. The P value is provided. C, RNA-seq data for Ptgs2 in three independent AKTFPR270H/+ and AKTFPR270H/LOH organoid lines. fragments per kilobase of exon per million reads mapped, the mean fold change, and P value are provided. D, Immunoblotting results for p53 and COX-2 in three independent AKTPNull and AKTPR270H lines. GAPDH was used as the internal control. E, Representative fluorescence immunocytochemistry images for p53 (green) and COX-2 (red) of AKTPNull (left) and AKTPR270H (right) organoids. F, Representative image of fluorescence IHC for p53 (green) and COX-2 (red) of AKTPR270H liver metastatic tumor. Insets in E and F show enlarged images. Bars in E and F, 100 μm. G, Representative images of fluorescence IHC for COX-2 (red) and F4/80 (macrophages, green) or αSMA (myofibroblasts, green). Merged images are shown (right). Bars, 50 μm. H, Luciferase activities of Wnt reporter assays (TOPFlash) of AKTPNull-bottom cells in co-cultured AKTPNull-top or AKTPR270H-top cells or control AKTPNull-bottom monoculture cells in the presence or absence of COX-2 inhibitor, celecoxib, are shown as a bar graph (mean ± SD). Each dot represents an independent experiment. The P value is indicated. ns, not significant. I and J, Luciferase activities of Wnt/β-catenin reporter assays in AKTPNull cells treated with PGE2 (I) or AKTPNull cells co-cultured with AKTPR270H treated with EP2/EP4 inhibitors (J) are shown as bar graphs (mean ± SD). Data from two independent AKTPNull lines (#1 and #2) are shown. Each dot indicates an independent experiment. P values are provided.
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 3 from Missense Mutant p53 Transactivates Wnt/β-Catenin Signaling in Neighboring p53-Destabilized Cells through the COX-2/PGE2 Pathway
Activation of Wnt/β-catenin signaling in p53-negative cells through the COX-2/PGE2 pathway. A, Schematic drawing of Wnt/β-catenin reporter assays (TOPFlash) of co-cultured AKTPNull-bottom cells with AKTPR270H-top cells or AKTPNull-top cells. B, Luciferase activities of Wnt reporter assays (TOPFlash) of AKTPNull-bottom cells co-cultured with AKTPNull-top cells or AKTPR270H-top cells are shown as a bar graph (mean ± SD). Each dot represents an independent experiment. The P value is provided. C, RNA-seq data for Ptgs2 in three independent AKTFPR270H/+ and AKTFPR270H/LOH organoid lines. fragments per kilobase of exon per million reads mapped, the mean fold change, and P value are provided. D, Immunoblotting results for p53 and COX-2 in three independent AKTPNull and AKTPR270H lines. GAPDH was used as the internal control. E, Representative fluorescence immunocytochemistry images for p53 (green) and COX-2 (red) of AKTPNull (left) and AKTPR270H (right) organoids. F, Representative image of fluorescence IHC for p53 (green) and COX-2 (red) of AKTPR270H liver metastatic tumor. Insets in E and F show enlarged images. Bars in E and F, 100 μm. G, Representative images of fluorescence IHC for COX-2 (red) and F4/80 (macrophages, green) or αSMA (myofibroblasts, green). Merged images are shown (right). Bars, 50 μm. H, Luciferase activities of Wnt reporter assays (TOPFlash) of AKTPNull-bottom cells in co-cultured AKTPNull-top or AKTPR270H-top cells or control AKTPNull-bottom monoculture cells in the presence or absence of COX-2 inhibitor, celecoxib, are shown as a bar graph (mean ± SD). Each dot represents an independent experiment. The P value is indicated. ns, not significant. I and J, Luciferase activities of Wnt/β-catenin reporter assays in AKTPNull cells treated with PGE2 (I) or AKTPNull cells co-cultured with AKTPR270H treated with EP2/EP4 inhibitors (J) are shown as bar graphs (mean ± SD). Data from two independent AKTPNull lines (#1 and #2) are shown. Each dot indicates an independent experiment. P values are provided.
- 20 February 2025
- Published by Elsevier in Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
- Vol. 1075
Estimation of contrast agents using a 2-dimensional photon counting CT detector combined with MPPC and YGAG scintillator array
- 20 February 2025
- Published by Elsevier in Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
- Vol. 1075
Estimation of contrast agents using a 2-dimensional photon counting CT detector combined with MPPC and YGAG scintillator array
- Open Access
- 3 January 2025
- Published by American Association for Cancer Research (AACR)
Data from Missense Mutant p53 Transactivates Wnt/β-Catenin Signaling in Neighboring p53-Destabilized Cells through the COX-2/PGE2 Pathway
Missense-type p53 mutations have shown to acquire novel oncogenic roles through a gain-of-function mechanism. However, there is intratumor heterogeneity in stabilization of mutant p53 protein, and it has not been well understood about the interaction between p53-stabilized and -destabilized cells in the same tumors. We established mouse intestinal tumor–derived organoids carrying ApcΔ716, KrasG12D, and Tgfbr2−/− mutations with Trp53R270H or Trp53Null mutation (AKTPR270H and AKTPNull, respectively). Using these organoids, we found that the activation level of Wnt/β-catenin signaling is significantly higher in AKTPR270H cells compared with AKTPNull cells. Notably, Wnt activation in the AKTPNull cells was significantly increased when co-cultured with AKTPR270H cells. Expression analysis revealed that COX-2 is significantly upregulated in AKTPR270H but not in AKTPNull cells, suggesting that mutant p53 induces the COX-2/prostaglandin E2 (PGE2) pathway. Importantly, Wnt activation in co-cultured AKTPNull cells with AKTPR270H was significantly suppressed when treated with the inhibitor of COX-2 or PGE2 receptors EP2/EP4. Furthermore, stimulation with PGE2 increased Wnt signaling activity in AKTPNull cells. These results indicate that the COX-2/PGE2 pathway is activated in the p53-stabilized cells in the missense-type p53-mutant cancer, and secreted PGE2 may transactivate Wnt/β-catenin signaling in neighboring p53-destabilized tumor cells in the intratumor microenvironment. Therefore, targeting stabilized mutant p53 or the COX-2/PGE2 pathway may suppress Wnt/β-catenin signaling of both mutant p53–stabilized and –destabilized cells; thus, this can be a possible preventive or therapeutic strategy.Significance:There is intratumor heterogeneity in the stabilization of missense mutant p53, and it has been thought that only cells with nuclear accumulation of mutant p53 have oncogenic function. However, using mouse intestinal tumor–derived organoids, we show that mutant p53–stabilized cells transactivate Wnt/β-catenin signaling in neighboring p53-destabilized cells through activating the COX-2/PGE2 pathway. These results suggest that both p53-stabilized cells and p53-destabilized cells contribute to malignant progression through interaction within the intratumor microenvironment.
- 3 January 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Missense Mutant p53 Transactivates Wnt/β-Catenin Signaling in Neighboring p53-Destabilized Cells through the COX-2/PGE2 Pathway
Missense-type p53 mutations have shown to acquire novel oncogenic roles through a gain-of-function mechanism. However, there is intratumor heterogeneity in stabilization of mutant p53 protein, and it has not been well understood about the interaction between p53-stabilized and -destabilized cells in the same tumors. We established mouse intestinal tumor–derived organoids carrying ApcΔ716, KrasG12D, and Tgfbr2−/− mutations with Trp53R270H or Trp53Null mutation (AKTPR270H and AKTPNull, respectively). Using these organoids, we found that the activation level of Wnt/β-catenin signaling is significantly higher in AKTPR270H cells compared with AKTPNull cells. Notably, Wnt activation in the AKTPNull cells was significantly increased when co-cultured with AKTPR270H cells. Expression analysis revealed that COX-2 is significantly upregulated in AKTPR270H but not in AKTPNull cells, suggesting that mutant p53 induces the COX-2/prostaglandin E2 (PGE2) pathway. Importantly, Wnt activation in co-cultured AKTPNull cells with AKTPR270H was significantly suppressed when treated with the inhibitor of COX-2 or PGE2 receptors EP2/EP4. Furthermore, stimulation with PGE2 increased Wnt signaling activity in AKTPNull cells. These results indicate that the COX-2/PGE2 pathway is activated in the p53-stabilized cells in the missense-type p53-mutant cancer, and secreted PGE2 may transactivate Wnt/β-catenin signaling in neighboring p53-destabilized tumor cells in the intratumor microenvironment. Therefore, targeting stabilized mutant p53 or the COX-2/PGE2 pathway may suppress Wnt/β-catenin signaling of both mutant p53–stabilized and –destabilized cells; thus, this can be a possible preventive or therapeutic strategy.Significance:There is intratumor heterogeneity in the stabilization of missense mutant p53, and it has been thought that only cells with nuclear accumulation of mutant p53 have oncogenic function. However, using mouse intestinal tumor–derived organoids, we show that mutant p53–stabilized cells transactivate Wnt/β-catenin signaling in neighboring p53-destabilized cells through activating the COX-2/PGE2 pathway. These results suggest that both p53-stabilized cells and p53-destabilized cells contribute to malignant progression through interaction within the intratumor microenvironment.
- Open Access
- 3 January 2025
- Published by American Association for Cancer Research (AACR)
Figure 4 from Missense Mutant p53 Transactivates Wnt/β-Catenin Signaling in Neighboring p53-Destabilized Cells through the COX-2/PGE2 Pathway
Promotion of cell proliferation of p53-negative tumor cells co-cultured with p53-mutant cells. A, Representative fluorescent immunocytochemistry images for p53 (red) and TOP-Venus–positive (Wnt/β-catenin–activated) cells (green) of monocultured AKTPNull (left) and co-cultured AKTPNull with AKTPR270H (right) organoids. Insets show enlarged images. Bars, 50 μm. B, Ratios of TOP-Venus–positive (Wnt/β-catenin–activated) cells per microscopic field. Each dot indicates the result in the independent field. Data from two independent AKTPNull lines (#1 and #2) are shown. P values are provided. C, Representative images of fluorescent immunocytochemistry for EdU-labeled cells (red) of monocultured AKTPNull (left) and co-cultured AKTPNull with Venus-labeled AKTPR270H organoids (green; right). Bars, 25 μm. D, Ratios of EdU-labeled cells to total monocultured AKTPNull cells or co-cultured AKTPNull cells with AKTPR270H. Each dot indicates the results in the independent microscopic field. Data from two independent AKTPNull lines (#1 and #2) are shown. P values are indicated. E, Representative photographs of monocultured AKTPNull (left) and AKTPR270H organoids (right) and co-cultured AKTPNull and AKTPR270H organoids (center). Results from two independent AKTPNull lines (#1 and #2) are shown. Bars, 200 μm. F, Relative organoid sizes of monocultured AKTPNull and AKTPR270H cells and co-cultured AKTPNull and AKTPR270H cells. Each dot indicates the independent organoid size. Results of two independent AKTPNull lines (#1 and #2) are shown. P values are shown. ns, not significant. G, Immunoblotting results for total β-catenin in two lines of sh-β-catenin–transfected AKTPNull cells and sh-control–transfected cells. GAPDH was used as the internal control. H, Relative cell growth rate of sh-β-catenin–transfected AKTPNull cells (#1 and #2) with sh-control–transfected cells. The results of two independent AKTPR270H lines are shown (G and H). Asterisks and daggers, P < 0.05 vs. sh-control.
- 3 January 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 4 from Missense Mutant p53 Transactivates Wnt/β-Catenin Signaling in Neighboring p53-Destabilized Cells through the COX-2/PGE2 Pathway
Promotion of cell proliferation of p53-negative tumor cells co-cultured with p53-mutant cells. A, Representative fluorescent immunocytochemistry images for p53 (red) and TOP-Venus–positive (Wnt/β-catenin–activated) cells (green) of monocultured AKTPNull (left) and co-cultured AKTPNull with AKTPR270H (right) organoids. Insets show enlarged images. Bars, 50 μm. B, Ratios of TOP-Venus–positive (Wnt/β-catenin–activated) cells per microscopic field. Each dot indicates the result in the independent field. Data from two independent AKTPNull lines (#1 and #2) are shown. P values are provided. C, Representative images of fluorescent immunocytochemistry for EdU-labeled cells (red) of monocultured AKTPNull (left) and co-cultured AKTPNull with Venus-labeled AKTPR270H organoids (green; right). Bars, 25 μm. D, Ratios of EdU-labeled cells to total monocultured AKTPNull cells or co-cultured AKTPNull cells with AKTPR270H. Each dot indicates the results in the independent microscopic field. Data from two independent AKTPNull lines (#1 and #2) are shown. P values are indicated. E, Representative photographs of monocultured AKTPNull (left) and AKTPR270H organoids (right) and co-cultured AKTPNull and AKTPR270H organoids (center). Results from two independent AKTPNull lines (#1 and #2) are shown. Bars, 200 μm. F, Relative organoid sizes of monocultured AKTPNull and AKTPR270H cells and co-cultured AKTPNull and AKTPR270H cells. Each dot indicates the independent organoid size. Results of two independent AKTPNull lines (#1 and #2) are shown. P values are shown. ns, not significant. G, Immunoblotting results for total β-catenin in two lines of sh-β-catenin–transfected AKTPNull cells and sh-control–transfected cells. GAPDH was used as the internal control. H, Relative cell growth rate of sh-β-catenin–transfected AKTPNull cells (#1 and #2) with sh-control–transfected cells. The results of two independent AKTPR270H lines are shown (G and H). Asterisks and daggers, P < 0.05 vs. sh-control.
- Open Access
- 3 January 2025
- Published by American Association for Cancer Research (AACR)
Figure 1 from Missense Mutant p53 Transactivates Wnt/β-Catenin Signaling in Neighboring p53-Destabilized Cells through the COX-2/PGE2 Pathway
Promotion of Wnt/β-catenin signaling in missense-type p53-mutant colon tumors. A, Luciferase activities of NF-κΒ reporter assay are shown as a bar graph (mean ± SD). B, Luciferase activities of Wnt/β-catenin reporter assay (TOPFlash) are shown as a bar graph (mean ± SD). Three independent AKTPNull and AKTPR270H organoid lines for each were used in the reporter assays (A and B). Statistical analysis was performed using the one-way ANOVA test (A and B). C, Luciferase activities of Wnt/β-catenin reporter assay for control-transfected and Trp53 siRNA–transfected AKTPR270H organoid cells are shown as a bar graph (mean ± SD). The immunoblotting result for p53 is shown. GAPDH was used as the internal control. Each dot in A–C graphs indicates an independent experiment. P values are indicated. D, Representative confocal microscopy images of fluorescence immunocytochemistry for β-catenin (green) and E-cadherin (red) in AKTPNull and AKTPR270H organoids. Arrowheads indicate cells with β-catenin stabilization. Bars, 25 μm. E, Representative photographs of fluorescence IHC for β-catenin (green) and E-cadherin (red) of AKTPNull and AKTPR270H liver metastatic tumors. Insets show enlarged images. Bars, 100 μm. Note that β-catenin accumulation was predominantly found in AKTPR270H tumors. F, Immunoblotting results for p53 in colorectal cancer cell lines. β-Actin was used as the internal control. G, Luciferase activities of Wnt/β-catenin reporter assay (TOPFlash) for colorectal cancer cell lines are shown as a bar graph (mean ± SD). Each dot indicates an independent experiment. The P value is provided. H, Representative photographs of immunostaining for p53 (left) and β-catenin (right) of p53-positive and β-catenin nuclear-accumulated (top) and p53-negative and β-catenin not nuclear–accumulated (bottom) human colorectal cancer. Insets show enlarged images of the boxed area. Arrowheads indicate p53 stabilization (left) and β-catenin nuclear accumulation (right). Bars, 200 μm. I, Ratio of β-catenin nuclear accumulation in p53-positive (+) and p53-negative (−) colorectal cancer scored using the IHC results in H. The P value is indicated.
- 3 January 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 1 from Missense Mutant p53 Transactivates Wnt/β-Catenin Signaling in Neighboring p53-Destabilized Cells through the COX-2/PGE2 Pathway
Promotion of Wnt/β-catenin signaling in missense-type p53-mutant colon tumors. A, Luciferase activities of NF-κΒ reporter assay are shown as a bar graph (mean ± SD). B, Luciferase activities of Wnt/β-catenin reporter assay (TOPFlash) are shown as a bar graph (mean ± SD). Three independent AKTPNull and AKTPR270H organoid lines for each were used in the reporter assays (A and B). Statistical analysis was performed using the one-way ANOVA test (A and B). C, Luciferase activities of Wnt/β-catenin reporter assay for control-transfected and Trp53 siRNA–transfected AKTPR270H organoid cells are shown as a bar graph (mean ± SD). The immunoblotting result for p53 is shown. GAPDH was used as the internal control. Each dot in A–C graphs indicates an independent experiment. P values are indicated. D, Representative confocal microscopy images of fluorescence immunocytochemistry for β-catenin (green) and E-cadherin (red) in AKTPNull and AKTPR270H organoids. Arrowheads indicate cells with β-catenin stabilization. Bars, 25 μm. E, Representative photographs of fluorescence IHC for β-catenin (green) and E-cadherin (red) of AKTPNull and AKTPR270H liver metastatic tumors. Insets show enlarged images. Bars, 100 μm. Note that β-catenin accumulation was predominantly found in AKTPR270H tumors. F, Immunoblotting results for p53 in colorectal cancer cell lines. β-Actin was used as the internal control. G, Luciferase activities of Wnt/β-catenin reporter assay (TOPFlash) for colorectal cancer cell lines are shown as a bar graph (mean ± SD). Each dot indicates an independent experiment. The P value is provided. H, Representative photographs of immunostaining for p53 (left) and β-catenin (right) of p53-positive and β-catenin nuclear-accumulated (top) and p53-negative and β-catenin not nuclear–accumulated (bottom) human colorectal cancer. Insets show enlarged images of the boxed area. Arrowheads indicate p53 stabilization (left) and β-catenin nuclear accumulation (right). Bars, 200 μm. I, Ratio of β-catenin nuclear accumulation in p53-positive (+) and p53-negative (−) colorectal cancer scored using the IHC results in H. The P value is indicated.
- Open Access
- 3 January 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Missense Mutant p53 Transactivates Wnt/β-Catenin Signaling in Neighboring p53-Destabilized Cells through the COX-2/PGE2 Pathway
Trp53 LOH analysis for AKTP R270H cells
- 3 January 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Missense Mutant p53 Transactivates Wnt/β-Catenin Signaling in Neighboring p53-Destabilized Cells through the COX-2/PGE2 Pathway
Trp53 LOH analysis for AKTP R270H cells
- Open Access
- 3 January 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Missense Mutant p53 Transactivates Wnt/β-Catenin Signaling in Neighboring p53-Destabilized Cells through the COX-2/PGE2 Pathway
IPA results for AKTP R270 vs AKTP Null cells
- 3 January 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Missense Mutant p53 Transactivates Wnt/β-Catenin Signaling in Neighboring p53-Destabilized Cells through the COX-2/PGE2 Pathway
IPA results for AKTP R270 vs AKTP Null cells